Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | TNF | P01375 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 4/20 | 0.31 |
| ▸ | MAOB | P27338 | 4/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.30 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15432052 | 0.98 | ATM (0.34) | KMT2AMAPTMEN1ALOX5HSP90AA1 | |
| SCHEMBL15432053 | 0.97 | KMT2A (0.33) | KMT2AMAPTMEN1ALOX5HSP90AA1 | |
| SCHEMBL12169063 | 0.93 | KDM4E (0.37) | KMT2AMAPTMEN1ALOX5HSP90AA1 | |
| SCHEMBL17366384 | 0.93 | KDM4E (0.37) | KMT2AMAPTMEN1ALOX5HSP90AA1 | |
| SCHEMBL12169047 | 0.93 | KMT2A (0.33) | KMT2AMAPTMEN1ALOX5HSP90AA1 | |
| SCHEMBL12168993 | 0.91 | KDM4E (0.39) | KMT2AMAPTMEN1ALOX5HSP90AA1 | |
| SCHEMBL12098192 | 0.91 | ATM (0.39) | KMT2AMAPTMEN1ALOX5HSP90AA1 | |
| SCHEMBL17618128 | 0.91 | KMT2A (0.36) | KMT2AMAPTMEN1ALOX5HSP90AA1 | |
| SCHEMBL8735558 | 0.91 | MAPT (0.34) | KMT2AMAPTMEN1ALOX5HSP90AA1 | |
| SCHEMBL12169048 | 0.91 | CYP17A1 (0.38) | TNFMAPK10CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8748014-B2 | Compound having a substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2014-06-10 | — | — | US | disclosed |
| US-8748014-B2 | Compound having a substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2014-06-10 | — | — | US | disclosed |
| US-20120228598-A1 | COMPOUND HAVING A SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-09-13 | — | — | US | disclosed |
| US-20120228598-A1 | COMPOUND HAVING A SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120228598-A1 | COMPOUND HAVING A SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | PNPO, OXA1L, NLRP1 | KMT2A 3469/4885MAPT 3298/4885MEN1 933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.